Aluminum phosphide sales will strengthen through 2036, anchored by tablets at 52% of the product form segment in 2026, driven by dosing precision and handling safety. The market was valued at USD 190.0 million in 2025 and is expected to be worth USD 265.8 million by 2036, creating an incremental opportunity of USD 69.9 million.